Table 1.
Changes in compositions of fatty acids in total glycerophospholipids from the tadpole liver
| FA | 3-day treatment | 7-day treatment | ||||||
|---|---|---|---|---|---|---|---|---|
| 26 °C | 4 °C | 26 °C | 4 °C | |||||
| T3 (−) | T3 (+) | T3 (−) | T3 (+) | T3 (−) | T3 (+) | T3 (−) | T3 (+) | |
| SFA | ||||||||
| 16:0 | 33.4 ± 0.5 | 32.9 ± 0.4 | 31.6 ± 0.2 | 32.0 ± 0.1 | 34.1 ± 0.7 | 33.5 ± 0.3 | 29.6 ± 0.6 | 31.6 ± 1.8 |
| 18:0 | 17.9 ± 1.2 | 17.3 ± 0.6 | 15.9 ± 0.1 | 15.4 ± 0.5 | 16.6 ± 0.4 | 18.4 ± 1.3 | 16.8 ± 0.2 | 18.6 ± 1.7 |
| MUFA | ||||||||
| 16:1n-7 | 5.8 ± 0.4 | 6.0 ± 0.3 | 7.8 ± 0.1 | 7.2 ± 0.1 | 5.5 ± 0.4 | 5.9 ± 0.7 | 5.7 ± 0.1 | 5.4 ± 0.3 |
| 18:1n-9 | 10.4 ± 0.8a | 11.6 ± 0.6a,b | 11.7 ± 0.1a,b | 13.1 ± 0.2b | 8.2 ± 0.4 | 11.0 ± 1.3 | 10.0 ± 0.6 | 9.7 ± 0.8 |
| C18 PUFA | ||||||||
| 18:2n-6 | 6.3 ± 0.2 | 7.5 ± 0.4 | 7.0 ± 0.3 | 6.9 ± 0.2 | 7.2 ± 0.6 | 6.9 ± 0.4 | 7.7 ± 0.4 | 6.8 ± 0.7 |
| 18:3n-3 | 4.6 ± 0.3 | 5.7 ± 0.3 | 5.4 ± 0.5 | 5.3 ± 0.3 | 6.7 ± 0.9 | 6.5 ± 1.6 | 10.7 ± 0.5 | 9.1 ± 1.0 |
| C20 PUFA | ||||||||
| 20:4n-6 | 9.8 ± 0.8 | 8.6 ± 0.4 | 8.2 ± 0.1 | 7.6 ± 0.3 | 10.5 ± 0.3a | 8.7 ± 0.6a,b | 8.4 ± 0.3b | 8.1 ± 0.3b |
| 20:5n-3 | 7.0 ± 0.2 | 5.4 ± 0.1 | 6.9 ± 0.2 | 6.5 ± 0.3 | 5.5 ± 0.3a | 3.7 ± 0.1b | 5.8 ± 0.2a | 5.7 ± 0.7a |
| C22 PUFA | ||||||||
| 22:5n-3 | 2.1 ± 0.1 | 2.3 ± 0.1 | 2.5 ± 0.2 | 2.5 ± 0.1 | 2.4 ± 0.2 | 2.6 ± 0.1 | 2.5 ± 0.1 | 2.4 ± 0.1 |
| 22:6n-3 | 2.9 ± 0.3 | 2.8 ± 0.1 | 3.0 ± 0.2 | 3.7 ± 0.1 | 3.2 ± 0.3 | 2.8 ± 0.3 | 2.8 ± 0.1 | 2.6 ± 0.2 |
18:1n-9 contains18:1n-9t (elaidic acid) and 18:1n-9c (oleic acid). Each value is the mean ± SEM (n = 3). Different letters indicate significantly different means and were determined by one-way analysis of variance with Fisher’s test for multiple comparisons (p < 0.05)
FA fatty acid, T3 3,3′,5-triiodothyronie, SFA saturated fatty acid, MUFA monounsaturated fatty acid, PUSA polyunsaturated fatty acid